Literature DB >> 17541162

Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against carbon tetrachloride toxicity in mouse livers.

Po Yee Chiu1, Hoi Yan Leung, Ada Hoi Ling Siu, Michel Kong Tat Poon, Kam Ming Ko.   

Abstract

Schisandrin B (Sch B), a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis, has been shown to protect against carbon tetrachloride (CCl4) hepatotoxicity in mice. In order to elucidate the molecular mechanism underlying the hepatoprotection afforded by Sch B, the effect of Sch B treatment on the sensitivity of mitochondria to Ca2+-stimulated permeability transition (PT) was investigated in mouse livers under normal and CCl4-intoxicated conditions. CCl4 hepatotoxicity caused an increase in the sensitivity of mitochondria to Ca2+-stimulated PT in vitro. The enhanced sensitivity to mitochondrial PT was associated with increases in mitochondrial Ca2+ content as well as the extent of reactive oxidant species (ROS) production and cytochrome c release. The hepatoprotection afforded by Sch B pretreatment against CCl4 toxicity was paralleled by the decrease in the sensitivity of hepatic mitochondria to Ca2+-stimulated PT as well as the attenuations of mitochondrial Ca2+ loading, ROS production and cytochrome c release under CCl4-intoxicated condition. In conclusion, the results suggest that the hepatoprotection afforded by Sch B pretreatment against CCl4 toxicity may be related to the increase in the resistance of hepatic mitochondria to Ca2+-stimulated PT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541162     DOI: 10.1248/bpb.30.1108

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.

Authors:  Jian-Hong Chu; Hui Wang; Yan Ye; Ping-Kei Chan; Si-Yuan Pan; Wang-Fun Fong; Zhi-Ling Yu
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Preservation on calcium homeostasis is involved in mitochondrial protection of Limonium sinense against liver damage in mice.

Authors:  Xin-Hui Tang; Jin Chen; Xiao-Lan Yang; Li-Fang Yan; Jing Gao
Journal:  Pharmacogn Mag       Date:  2010-07       Impact factor: 1.085

3.  Schisandrin B inhibits the proliferation of human lung adenocarcinoma A549 cells by inducing cycle arrest and apoptosis.

Authors:  Xue-Jiao Lv; Li-Jing Zhao; Yu-Qiu Hao; Zhen-Zhong Su; Jun-Yao Li; Yan-Wei Du; Jie Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  The Cytochrome P450-Mediated Metabolism Alternation of Four Effective Lignans From Schisandra chinensis in Carbon Tetrachloride-Intoxicated Rats and Patients With Advanced Hepatocellular Carcinoma.

Authors:  Rongrong Wu; Zhiyong Xiao; Xiaorui Zhang; Feng Liu; Wenxia Zhou; Yongxiang Zhang
Journal:  Front Pharmacol       Date:  2018-03-14       Impact factor: 5.810

5.  A Network Pharmacology-Based Study on the Hepatoprotective Effect of Fructus Schisandrae.

Authors:  Ming Hong; Yongsheng Zhang; Sha Li; Hor Yue Tan; Ning Wang; Shuzhen Mu; Xiaojiang Hao; Yibin Feng
Journal:  Molecules       Date:  2017-09-28       Impact factor: 4.411

Review 6.  Antioxidant Effects of Schisandra chinensis Fruits and Their Active Constituents.

Authors:  Dalia M Kopustinskiene; Jurga Bernatoniene
Journal:  Antioxidants (Basel)       Date:  2021-04-18

7.  Schisandrin B Diet Inhibits Oxidative Stress to Reduce Ferroptosis and Lipid Peroxidation to Prevent Pirarubicin-Induced Hepatotoxicity.

Authors:  Hongwei Shi; Yue Yan; Hong Yang; Peng Pu; Heng Tang
Journal:  Biomed Res Int       Date:  2022-07-18       Impact factor: 3.246

8.  Schisandra chinensis peptidoglycan-assisted transmembrane transport of lignans uniquely altered the pharmacokinetic and pharmacodynamic mechanisms in human HepG2 cell model.

Authors:  Charng-Cherng Chyau; Yaw-Bee Ker; Chi-Huang Chang; Shiau-Huei Huang; Hui-Er Wang; Chiung-Chi Peng; Robert Y Peng
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.